2009
DOI: 10.1016/j.exger.2009.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
53
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(66 citation statements)
references
References 21 publications
11
53
2
Order By: Relevance
“…The percentage of CD4 + T cells expressing PD-1 was increased in the spleen of aged C57Bl/6 mice (≥ 16-month old) compared to young mice (≤ 2-month old) as already described (Channappanavar et al 2009; Shimada et al 2009; Shimatani et al 2009), as well as in lymph nodes (LN) and lungs (Figure 1A and Table I). The same significant increase was observed when intracellular expression of PD-1 was measured in CD4 + T cells from the spleen (32.2 ± 7.2% in aged mice versus 7.5 ± 1.4% in young mice; p<0.05), the LN (11.2 ± 1.0% in aged mice versus 7.1 ± 0.6% in young mice; p=0.01), or the lung (19.2 ± 4.5% in aged mice versus 5.1 ± 0.3% in young mice; p=0.03).…”
Section: Resultssupporting
confidence: 80%
“…The percentage of CD4 + T cells expressing PD-1 was increased in the spleen of aged C57Bl/6 mice (≥ 16-month old) compared to young mice (≤ 2-month old) as already described (Channappanavar et al 2009; Shimada et al 2009; Shimatani et al 2009), as well as in lymph nodes (LN) and lungs (Figure 1A and Table I). The same significant increase was observed when intracellular expression of PD-1 was measured in CD4 + T cells from the spleen (32.2 ± 7.2% in aged mice versus 7.5 ± 1.4% in young mice; p<0.05), the LN (11.2 ± 1.0% in aged mice versus 7.1 ± 0.6% in young mice; p=0.01), or the lung (19.2 ± 4.5% in aged mice versus 5.1 ± 0.3% in young mice; p=0.03).…”
Section: Resultssupporting
confidence: 80%
“…It has been proposed that impaired T‐cell function during aging is associated with an increase in the population of PD‐1‐expressing T cells (Channappanavar et al ., 2009; Shimada et al ., 2009; Lages et al ., 2010; Decman et al ., 2012). To address the relationship between the exhaustion of T cells and aging more specifically, we examined the expression of Tim‐3, which, along with PD‐1, defines T‐cell exhaustion during chronic infection or in tumors (Jin et al ., 2010; Sakuishi et al ., 2010) but has never been studied in a model of aging.…”
Section: Resultsmentioning
confidence: 99%
“…From the standpoint of T‐cell senescence and intrinsic alterations of T‐cell signaling, it is important to study the roles of inhibitory molecules in aged T cells (Fulop et al ., 2014). Recently, CD4 + and CD8 + T cells from aged mice have been shown to express several inhibitory receptor molecules, including PD‐1, LAG‐3, CTLA‐4, and KLRG1, all of which may be associated with defective T‐cell responses (Channappanavar et al ., 2009; Shimada et al ., 2009; Decman et al ., 2012). It has also been suggested that a PD‐1 blockade may partially restore T‐cell function (Lages et al ., 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Age-associated predominance of ICOS-expressing T-cells has been described in mice (Channappanavar et al 2009), yet to our knowledge, no data on its expression in aged human subjects exist. Results regarding the Treg marker Foxp3 and the inhibitory T-cell receptor CTLA-4 are somewhat controversial both in aged humans and mice (Channappanavar et al 2009;Hwang et al 2009;Leng et al 2002;Shimada et al 2009;Tsaknaridis et al 2003;Wakikawa et al 1997). Nevertheless, it must be noted that direct conclusions on the equality of immunosenescence in mice and humans are rather questionable and most importantly, examination of only a few molecules at a time does not give a comprehensive picture of ''net'' immunocompetence in vivo.…”
Section: Introductionmentioning
confidence: 91%